Korean researchers have discovered a specific protein that promotes lupus and nephritis, opening the possibility of developing a treatment.Ulsan National Institute of Science and Technology (UNIST) announced Tuesday that its research team, led by Professor Kwon Hyug-moo of the Department of Biologic
Starting in October, the government will reduce health insurance coverage for brain and cerebrovascular MRI examinations.The Ministry of Health and Welfare said Monday it has revised the notice on “details on the application standards and methods of benefits” to that effect. The revised notice will
Heart failure poses significant challenges in both diagnosis and treatment. However, in recent times, the landscape of managing this condition has undergone a transformative shift with the introduction of numerous new drugs. A notable example is the use of sodium-glucose co-transporter-2 (SGLT-2) in
SK Biopharmaceuticals, the company behind the successful 2020 launch of epilepsy treatment cenobamate (U.S. product name: Xcopri) in the U.S., is now setting its sights on becoming a well-rounded big biotech enterprise.Speaking at a press conference on Tuesday, SK biopharmaceuticals CEO Lee Dong-hoo
SK Group said it has selected Brain Asset Management, a Korean private equity fund, as the preferred bidder for the pre-initial public offering (IPO) financing of its contract development and manufacturing organization (CDMO) subsidiary SK pharmteco.SK held the preliminary bidding round in May throu
In the ever-evolving landscape of pharmaceutical logistics, Marken aims to become a trailblazer, offering logistic services tailored exclusively to the biopharma industry.To get more in-depth knowledge about the sector, Korea Biomedical Review recently met with Mary Ahn, Country Manager of Marken Ko
Prestige BioPharma, a Singapore-based pharmaceutical company specializing in antibody biopharmaceuticals, said on Tuesday that it joined the Cancer Moonshot Project promoted by U.S. President Joe Biden. This is the first time a Kospi-listed company and antibody drug developer has joined the Cancer M
An AI-powered cardiac arrest prediction system recently saved the life of a hospitalized patient at Uijeongbu Eulji Medical Center (UEMC), located in Gyeonggi Province to the north of Seoul.According to the hospital, Professor Sun Hyun-woo and nurse Hong Moon-seok at the Rapid Response Team were con
Seoul National University Hospital (SNUH) said on Tuesday that it will receive a donation of 30 billion won ($23.7 million) from Naver Corp, the nation's internet portal giant, to support research in digital biotech for three years. This donation marks the largest single research support fund donati
HLB said the U.S. Food and Drug Administration (FDA) has initiated a review for approving a combination therapy of rivoceranib and camrelizumab as the first-line treatment for hepatocellular carcinoma (HCC).The company filed a new drug application (NDA) in May.HLB Group Chairman Jin Yang-gon said on
GI Innovation expressed its intention to pursue a license out deal for GI-301, an allergy treatment, with Japanese companies at a press conference at the Grand InterContinental Seoul Parnas Hotel, in southern Seoul, on Monday. "We are currently in talks with three Japanese pharmaceutical companies t
Boehringer Ingelheim has launched Esgliteo (empagliflozin/linagliptin), a compound therapy of the SGLT-2 inhibitor Jardiance (empagliflozin) and the DPP-4 inhibitor Trajenta (linagliptin), with insurance coverage in Korea.Boehringer Ingelheim on Monday announced the domestic launch of Esgliteo (empa
GC said it has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for Alyglo, its 10 percent intravenous immunoglobulin.Alyglo, sold under the brand name IVIG-SN 10 percent in Korea, is a liquid immunoglobulin preparation purified from plasma fractions.Kor
Amid a protracted labor conflict at MSD Korea due to the company’s decision to abolish its general medicine (GM) division, the management has expanded the eligibility for its early retirement program (ERP) while increasing compensation money.MSD Korea recently announced the expansion of the ERP to a
A team of researchers at Yonsei University College of Medicine (YUCM) succeeded in developing a deep learning-based model to diagnose autism spectrum disorder (ASD) and determine its severity. ASD is a neurodevelopmental disorder characterized by abnormal patterns of social interaction and communica
"We must keep the hard-won flame alive. It is imperative to increase the self-reliance in active pharmaceutical ingredients (API) to establish pharmaceutical sovereignty by improving the self-sufficiency rate of medicines."Han Ssang-soo, who chairs the Special Committee for API within the Korea Phar
Korea is seeing an increase in malaria cases again. Malaria is a vector-borne disease that is transmitted through mosquitoes. It is known as one of the infectious diseases with the highest global burden of disease, with approximately 247 million cases in 84 countries in 2021, according to the World
Handok recalls part of the domestic supply of its antiepileptic treatment, Sabril Tab 500mg (vigabatrin), likely exacerbating the drug’s supply shortage.According to the Ministry of Food and Drug Safety (MFDS), Handok has recalled some batches of Sabril 500 mg (manufacturing number SAFA001) since la
Benign prostatic hyperplasia (BPH) is a prevalent ailment in men, with 1.35 million Korean men seeking medical attention in 2021 alone. While it is uncommon in younger men, middle-aged and older men aged 50 and above are primarily affected, with its development linked to male hormones and the aging
A research team at Korea University Anam Hospital (KUAH) found that patients with depression have higher expression levels of inflammation-related genes than those without depression.Depression is known to have a variety of biological causes. Recently, it has been suggested that chronic inflammatory